Wellington Management Group LLP 13D and 13G filings for Apogee Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-05 1:44 pm Purchase | 2025-07-31 | 13G | Apogee Therapeutics, Inc. APGE | Wellington Management Group LLP | 4,885,146 10.600% | 1,079,436 (+28.36%) | Filing |
| 2025-08-05 1:35 pm Sale | 2025-06-30 | 13G | Apogee Therapeutics, Inc. APGE | Wellington Management Group LLP | 3,805,710 8.300% | -1,680,044 (-30.63%) | Filing |
| 2025-05-12 10:44 am Purchase | 2025-03-31 | 13G | Apogee Therapeutics, Inc. APGE | Wellington Management Group LLP | 5,485,754 11.900% | 671,354 (+13.94%) | Filing |
| 2024-10-04 10:05 am Purchase | 2024-09-30 | 13G | Apogee Therapeutics, Inc. APGE | Wellington Management Group LLP | 4,814,400 10.700% | 4,814,400 (New Position) | Filing |